Little known biopharma company, NovaBay Pharmaceuticals, soared 874.8% in one day after having its product made available in

Sharing is Caring!

NovaBay Pharmaceuticals Launches Avenova® Direct on


Original formulation of Avenova® for the management of bacterial dry eye is now available at an affordable price without a prescription

We are primarily funded by readers. Please subscribe and donate to support us!

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces that Avenova® Direct is available at affordable pricing and without a prescription on through the Company’s new direct-to-consumer online channel. Avenova, the leading lid and lash spray, is designed for the removal of bacteria and debris on and around the eyelid margin that contribute to bacterial eye infections, which represent approximately 85% of the dry eye market. The Avenova Direct page on is available here.

complete press release:



h/t markyu007


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.